Skip to main content

Table 2 Clinical and Biochemical Characteristics of the non-NASH Patients and NASH Patients

From: Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

 

Non-NASH patients

NASH patients

P value

Age (years)

49.0 ± 15.3

52.8 ± 13.5

0.2995

BMI (m/kg2)

27.6 ± 5.1

28.9 ± 6.0

0.3989

VFA (cm2)

128.6 ± 55.7

133.3 ± 58.8

0.8031

SFA (cm2)

196.9 ± 61.4

232.5 ± 120.9

0.3765

AST (U/ml)

35.7 ± 17.5

63.4 ± 40.7

0.0031

ALT (U/ml)

56.8 ± 31.5

89.9 ± 55.7

0.0115

FBS (mg/dl)

118.7 ± 39.9

118.2 ± 30.8

0.9586

IRI (ul/ml)

13.6 ± 10.8

14.3 ± 8.2

0.7999

HOMA-IR

3.47 ± 2.64

4.05 ± 2.54

0.4725

HDL cholesterol (mg/l)

50.3 ± 12.6

49.3 ± 11.4

0.7463

LDL cholesterol (mg/l)

133.7 ± 27.0

128.6 ± 39.3

0.5928

Triglyceride (mg/l)

159.0 ± 48.9

162.8 ± 81.9

0.8502

Albumin

4.51 ± 0.28

4.45 ± 0.51

0.6175

Platelet count

25.8 ± 5.7

23.2 ± 8.0

0.1816

Hyaluronic acid (ng/dl)

21.6 ± 15.1

50.1 ± 50.2

0.0373

Type IV collagen 7s (ng/dl)

4.41 ± 0.98

5.14 ± 1.31

0.0611

  1. Data are expressed as means ± SD. VFA: visceral fat area, SFA: subcutaneous fat area, AST: aspartate aminotransferase, ALT: alanine aminotransferase, FBS: fasting blood sugar, IRI: immunoreactive insulin, HOMA-IR: homeostasis model assessment of insulin resistance.